PLoS ONE (Jan 2016)

STEMI Outcomes in Guangzhou and Hong Kong: Two-Centre Retrospective Interregional Study.

  • Xiaohui Chen,
  • Min Li,
  • Huilin Jiang,
  • Yunmei Li,
  • Junrong Mo,
  • Peiyi Lin,
  • Colin A Graham,
  • Timothy H Rainer

DOI
https://doi.org/10.1371/journal.pone.0149981
Journal volume & issue
Vol. 11, no. 3
p. e0149981

Abstract

Read online

BACKGROUND AND OBJECTIVES:Healthcare systems are organized very differently in Hong Kong (HK) and Guangzhou (GZ). This study compared managements of the emergency departments (ED) and one-year mortalities of ST-segment elevation myocardial infarction (STEMI) patients in two teaching hospitals in Guangzhou and Hong Kong. METHODS:Retrospective observational study of STEMI mortalities and treatments in the Prince of Wales Hospital (PWH) and the Second Affiliated Hospital of Guangzhou Medical University (AHGZMU), was conducted between January and December 2010. The primary outcome was one-year all cause mortality. RESULTS:Univariate analysis of 76 cases from PWH and 111 cases from AHGZMU showed similar clinical characteristics, except for lower proportions of males (74% vs 92%, P = 0.002), hyperlipidemia (5% vs 25%, P67 years) and hyperglycemia (>10 mmol/L). Aged over 65 years, presence of anterior wall infarct, body weight ≤65 kg, SBP 10 mmol/L were the independent predictors of in-hospital MACE. CONCLUSION:There was no statistically significant difference between the standardized one-year all-cause mortalities of STEMI patients in the setting mainly using thrombolysis with shorter door-to-treatment time and the setting mainly using PCI with longer door-to-treatment time. Aged over 67 years and glucose level over 10 mmol/L were the independent predictors of one-year mortality. Older age, presence of anterior wall infarct, lower body weight, lower SBP at ED and hyperglycemia were the independent predictors of in-hospital MACE.